Your browser doesn't support javascript.
loading
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.
Zhang, Erhao; Gu, Jieyi; Xue, Jianpeng; Lin, Chenyu; Liu, Chen; Li, Mengwei; Hao, Jingchao; Setrerrahmane, Sarra; Chi, Xiaowei; Qi, Weiyan; Hu, Jialiang; Xu, Hanmei.
Afiliação
  • Zhang E; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Gu J; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Xue J; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Lin C; State Key Laboratory of Natural Medicines, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Liu C; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Li M; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Hao J; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Setrerrahmane S; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Chi X; School of Pharmaceutical Sciences and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, People's Republic of China.
  • Qi W; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Hu J; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
  • Xu H; The Engineering Research Center of Peptide Drug Discovery and Development, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
J Hematol Oncol ; 11(1): 44, 2018 03 20.
Article em En | MEDLINE | ID: mdl-29558951
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Proteínas Angiogênicas / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Proteínas Angiogênicas / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article